Speech-Language Pathologists in Falconer, NY Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Elizabeth Kazan Giddy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 East Ave, Falconer, NY 14733 Phone: 716-665-6624 |
Mrs. Krystle Marie Haglund, M.S. SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 East Ave N, Falconer, NY 14733 Phone: 716-665-6624 |
Pamela S. Eckendorf, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1517 Route 394, Falconer, NY 14733 Phone: 716-661-3564 |
Ms. Beth Anne Kruse, M.S.CCC/SLP-L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 129 E Mosher St, Falconer, NY 14733 Phone: 716-665-4544 |
Marah Micek Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 East Ave N, Falconer, NY 14733 Phone: 716-665-6668 |
News Archive
GNA Biosolutions named as winner of AACC Disruptive Technology Award
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry's (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. GNA Biosolutions also won the audience choice award.
Antibody target implicated in neuropsychiatric symptoms of lupus discovered
Researchers have identified a specific target of antibodies that are implicated in the neuropsychiatric symptoms of lupus, according to human research published in JNeurosci.
Roche makes offer to acquire Ventana Medical Systems
Roche will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems for $75.00 per share in cash, or an aggregate of approximately $3 billion on a fully diluted basis.
A study on hospitalized COVID-19 patients who received plasma therapy
A new study has been published which focuses on the evaluation of the outcomes of infected COVID-19 patients who were treated with CCP therapy.
Tumorigenesis may be induced from neighboring tissues, study suggests
Current view is that cancer development is initiated from cells that acquire initial DNA mutations. These in turn provoke additional defects, and ultimately the affected cells begin to proliferate in an uncontrolled manner to develop primary tumors.
› Verified 3 days ago
Speech-Language Pathologists
Chiropractors
Occupational Therapists